Sameer Mathur
Allergy and Immunology Residency · University of Wisconsin Hospitals and Clinics
Credentials: · · ·
History
Research
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study
American Journal of Respiratory and Critical Care Medicine · 2011 · 562 citations
Journal of Allergy and Clinical Immunology · 2011 · 199 citations
Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway
Molecular and Cellular Biology · 1998 · 174 citations
18 papers
9 papers
9 papers · 1 as a resident
8 papers
- DM
7 papers
7 papers
- DL
6 papers
- DB
6 papers
Grants
- 2000–2020
Wisconsin Allergy Research Training (WiscART) Program
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $544.5K · University of Wisconsin-Madison
- 2016–2019
Eosinophil beta1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $420.8K · University of Wisconsin-Madison
Clinical trials
- 2016–2018
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
Principal investigator · Completed
University of Wisconsin, Madison